PL1616195T3 - Rozpoznawanie stanu przedrzucawkowego - Google Patents

Rozpoznawanie stanu przedrzucawkowego

Info

Publication number
PL1616195T3
PL1616195T3 PL04728206T PL04728206T PL1616195T3 PL 1616195 T3 PL1616195 T3 PL 1616195T3 PL 04728206 T PL04728206 T PL 04728206T PL 04728206 T PL04728206 T PL 04728206T PL 1616195 T3 PL1616195 T3 PL 1616195T3
Authority
PL
Poland
Prior art keywords
eclampsia
adma
iugr
inhibition
prevention
Prior art date
Application number
PL04728206T
Other languages
English (en)
Polish (pl)
Inventor
Makrina Savvidou
Aroon Hingorani
P Vallance
Kypros Nicolaides
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Publication of PL1616195T3 publication Critical patent/PL1616195T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/471Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/36Gynecology or obstetrics
    • G01N2800/368Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Environmental Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Animal Husbandry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL04728206T 2003-04-17 2004-04-19 Rozpoznawanie stanu przedrzucawkowego PL1616195T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0308967.9A GB0308967D0 (en) 2003-04-17 2003-04-17 Screen for pre-eclampsia
PCT/GB2004/001701 WO2004095032A1 (en) 2003-04-17 2004-04-19 Screen for pre-eclampsia
EP04728206A EP1616195B1 (en) 2003-04-17 2004-04-19 Screen for pre-eclampsia

Publications (1)

Publication Number Publication Date
PL1616195T3 true PL1616195T3 (pl) 2008-03-31

Family

ID=9956995

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04728206T PL1616195T3 (pl) 2003-04-17 2004-04-19 Rozpoznawanie stanu przedrzucawkowego

Country Status (14)

Country Link
US (1) US20070185200A1 (cg-RX-API-DMAC7.html)
EP (1) EP1616195B1 (cg-RX-API-DMAC7.html)
JP (1) JP4489070B2 (cg-RX-API-DMAC7.html)
CN (1) CN1802566A (cg-RX-API-DMAC7.html)
AT (1) ATE377757T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004232835B2 (cg-RX-API-DMAC7.html)
CA (1) CA2522285C (cg-RX-API-DMAC7.html)
DE (1) DE602004009909T2 (cg-RX-API-DMAC7.html)
DK (1) DK1616195T3 (cg-RX-API-DMAC7.html)
ES (1) ES2295857T3 (cg-RX-API-DMAC7.html)
GB (1) GB0308967D0 (cg-RX-API-DMAC7.html)
NZ (1) NZ543067A (cg-RX-API-DMAC7.html)
PL (1) PL1616195T3 (cg-RX-API-DMAC7.html)
WO (1) WO2004095032A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090053741A1 (en) * 2005-03-30 2009-02-26 Patrick John Thompson Vallance Assay for measuring asymmetric methylarginine in a biological sample
GB0600916D0 (en) * 2006-01-17 2006-02-22 Perkinelmer Instr Las Inc detecting and predicting pre-eclampsia
CA2644499A1 (en) * 2006-03-02 2007-09-13 Perkinelmer Las, Inc. Methods for distinguishing isomers using mass spectrometry
WO2010091253A1 (en) 2009-02-06 2010-08-12 Women & Infants' Hospital Of Rhode Island Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
CA2759534C (en) * 2009-04-23 2018-03-27 Wallac Oy Method for determining maternal health risks
HRP20150802T1 (xx) * 2010-03-24 2015-11-06 Preelumina Diagnostics Ab Hbf i a1m kao markeri za rano otkrivanje preeklampsije
US20130130278A1 (en) * 2011-11-22 2013-05-23 Ottawa Hospital Research Institute Detection of risk for pregnancy-related medical conditions
IN2014CN03826A (cg-RX-API-DMAC7.html) * 2011-11-30 2015-10-16 Koninkl Philips Nv
CN102628868B (zh) * 2011-12-30 2014-09-17 北京九强生物技术股份有限公司 检测非对称二甲基精氨酸含量的胶乳增强免疫比浊法试剂盒
RU2754956C1 (ru) * 2021-04-06 2021-09-08 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии у беременных с синдромом задержки роста плода

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811416A (en) * 1994-06-06 1998-09-22 Board Of Regents The University Of Texas System Endothelin antagonist and/or endothelin synthase inhibitor in combination with a progestin, an estrogen, a cyclooxygenase inhibitor, or a nitric acid donor or substrate
DE10040904A1 (de) * 2000-08-18 2002-02-28 Boeger Rainer H Verfahren und Mittel zum Nachweis einer Wahrscheinlichkeit zukünftigen Fortschreitens von Gefässerkrankungen
AU2003290784A1 (en) * 2002-11-15 2004-06-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for detecting asymmetric dimethylarginine in a biological sample

Also Published As

Publication number Publication date
CA2522285C (en) 2013-01-22
AU2004232835B2 (en) 2009-10-22
EP1616195B1 (en) 2007-11-07
DK1616195T3 (da) 2008-03-10
US20070185200A1 (en) 2007-08-09
CA2522285A1 (en) 2004-11-04
GB0308967D0 (en) 2003-05-28
NZ543067A (en) 2008-04-30
AU2004232835A1 (en) 2004-11-04
CN1802566A (zh) 2006-07-12
JP2006524325A (ja) 2006-10-26
DE602004009909D1 (de) 2007-12-20
DE602004009909T2 (de) 2008-08-28
JP4489070B2 (ja) 2010-06-23
HK1081269A1 (en) 2006-05-12
EP1616195A1 (en) 2006-01-18
WO2004095032A1 (en) 2004-11-04
ATE377757T1 (de) 2007-11-15
ES2295857T3 (es) 2008-04-16

Similar Documents

Publication Publication Date Title
GB0308967D0 (en) Screen for pre-eclampsia
AU2003272374A8 (en) Processing of transactions with expanded card acceptance
DE602004017045D1 (de) Graduierte östrogen-kontrazeptiva
TR200001460T2 (tr) Çok düşük estrojen dozları kullanılarak menopoz sonrası kadınların tedavisine yönelik metodlar
IL144224A0 (en) ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
IL233205A0 (en) Methods for diagnosing a pregnant woman with pre-eclampsia or eclampsia or with a tendency to develop pre-eclampsia or eclampsia
CA2447147A1 (en) Determination of pregnancy status
WO2005037059A3 (en) Multi-marker screening protocol for fetal abnormalities
WO2002003834A3 (en) Modular maternity mattress system
ATE321558T1 (de) Progesterone zur behandlung oder minderung von ischemie in menopause befindlichen frauen, die östrogen bekommen
CY1111213T1 (el) Ελαττωση του κινδυνου επιπλοκων πρωιμοτητας
DE60204262D1 (de) Körperfettmesssystem für schwangere Frauen
EP1282432A4 (en) METHOD OF USING ZONULIN PEPTIDE ANTAGONISTS TO PREVENT OR DELAY THE APPEARANCE OF DIABETES
ZA200306106B (en) Phosphorous removal and diene removal, when using diene sensitive catalyst, during conversion of olefins to branched primary alcohols.
DE60313217D1 (de) Flüssiger abbindebeschleuniger für portlandzement enthaltende zusammensetzung
SG166107A1 (en) Quadraphasic continuous graduated estrogen contraceptive
GB2446997A (en) Memory access request arbitration
WO2004072638A8 (en) Non-invasive assessment of intra-amniotic environment
IL160254A0 (en) Mullerian inhibiting substance levels and ovarian response
HUP0104408A2 (hu) Mammaglobin, egy szekretált emlőspecifikus mellrák fehérje
WO2003089001A8 (en) Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus
JP2006524325A5 (cg-RX-API-DMAC7.html)
YU30003A (sh) Inhibicija zavisnosti faktora rasta na ćelije tumora
TW200604807A (en) Method and system to order memory operations
WO2004058999A3 (de) Verfahren und mittel zur bestimmung von bestimmten zuständen bzw. veränderungen im uterusepithel und im epithel anderer organe